Equities

Clover Health Investments Corp

Clover Health Investments Corp

Actions
  • Price (EUR)2.68
  • Today's Change-0.005 / -0.19%
  • Shares traded320.00
  • 1 Year change+159.73%
  • Beta--
Data delayed at least 15 minutes, as of Sep 19 2024.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of USD
(except for per share items)
Fiscal data as of Dec 31 2023202320222021
ASSETS
Cash And Short Term Investments298435628
Total Receivables, Net9214762
Total Inventory------
Prepaid expenses14189.41
Other current assets, total232453
Total current assets428625753
Property, plant & equipment, net8.469.787.65
Goodwill, net------
Intangibles, net2.99204.23
Long term investments121138176
Note receivable - long term------
Other long term assets101610
Total assets571809951
LIABILITIES
Accounts payable------
Accrued expenses232618
Notes payable/short-term debt000
Current portion long-term debt/capital leases------
Other current liabilities, total201373326
Total current liabilities261432373
Total long term debt0020
Total debt0020
Deferred income tax------
Minority interest----3.90
Other liabilities, total232019
Total liabilities284452415
SHAREHOLDERS EQUITY
Common stock0.050.050.05
Additional paid-in capital2,4612,3192,154
Retained earnings (accumulated deficit)(2160)(1946)(1617)
Treasury stock - common(13)(6.51)(0.15)
Unrealized gain (loss)------
Other equity, total(2.37)(9.37)(1.93)
Total equity286357535
Total liabilities & shareholders' equity571809951
Total common shares outstanding489478471
Treasury shares - common primary issue7.912.070.01
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.